Radioligand Therapies (RLTs) and Healthcare System Readiness: From the Experience in GEP-NET, a Retrospective Analysis on DRG and Mobility to Improve the Accessibility to the Future RLT in Italy
The study underscores the need for regulatory adjustments, resource allocation improvements, and healthcare system adaptations to effectively support innovative therapies for GEP-NETs. Addressing these needs is essential to optimize patient outcomes and address regional disparities in Italy's healthcare system.
Authors
- Marco Maccauro (ORCID: https://orcid.org/0000-0003-1389-3250)
- Matteo Scortichini
- Francesco Panzuto (ORCID: https://orcid.org/0000-0003-2789-4289)
- Alfredo Muni
- Paolo Sciattella (ORCID: https://orcid.org/0000-0002-8364-1895)
Institutions
- University of Rome Tor Vergata (IT)
- Ospedale Santa Chiara (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1007/s40261-025-01471-6
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Advanced Accelerator Applications
- Università degli Studi di Roma Tor Vergata